Abstract

Active surveillance may be considered for low-risk basal cell carcinomas (BCC) in patients with limited life expectancy; however, estimates of life expectancy are not readily available. Veterans Health Administration's (VHA) Care Assessment Need (CAN) score may address this problem.We examined the CAN score's performance in predicting 1-, 3-, and 5-year mortality in United States (US) veterans with BCC.This retrospective cohort study used national VHA electronic medical record data. The CAN score's performance in the prediction of mortality in veterans with BCC was evaluated based on tests of goodness-of-fit, discrimination, and calibration.For 54,744 veterans with BCC treatment encounters between 2013 and 2018, the CAN score performed well in the prediction of mortality based on multiple tests. A threshold CAN score of 90 had a positive predictive value of 55% for 3-year mortality, clinically useful in identifying patients with intermediate-term survival.The study relied upon the combination of diagnosis codes and procedures codes to identify BCC cases.The CAN score has the potential to improve the quality of cancer care for veterans by providing clinicians with an estimate of life expectancy and facilitating conversations in cases where active surveillance can be considered.

View details for DOI 10.1016/j.jaad.2023.09.029

View details for PubMedID 37742837